Literature DB >> 30698354

Takayasu arteritis: A distinct syndrome of large vessel vasculitis: A view point by late Professor Paul Bacon.

Ramnath Misra1.   

Abstract

Takayasu arteritis (TA), despite being classified as a large vessel vasculitis, has distinct genetic, pathological and clinical features as compared to giant cell arteritis. It is a rare disease seen more commonly in Asian countries. The challenge lies in assessing the degree of inflammation in a narrowed vessel and immunosuppressive therapy improves inflammatory features but is unable to open up an occluded vessel. It may have a positive effect on retarding further occlusion. Like antineutrophil cytoplasmic antibody-associated vasculitis, TA needs a collaborative effort to do randomized controlled therapy to provide benefit to patients.
© 2019 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30698354     DOI: 10.1111/1756-185X.13383

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  2 in total

1.  18F-FDG PET/CT plays a unique role in the management of Takayasu arteritis patients with atypical manifestations.

Authors:  Jiali Fan; Dongmei Wei; Huimin Zhang; Xiaoxin Sun; Jun Cai; Luyun Fan; Jiachen Yu; Wenjun Ma; Lei Song; Xianliang Zhou
Journal:  Clin Rheumatol       Date:  2020-06-19       Impact factor: 2.980

2.  18F-FDG PET/CT in the diagnosis of Takayasu arteritis: A case report.

Authors:  Na Chen; Jin-Bai Huang
Journal:  Radiol Case Rep       Date:  2021-12-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.